Usher in the growth turning point, seize the opportunity of The Times - Chairman Shi Yuanyuan made a keynote report at the group's general meeting of staff

In order to thoroughly implement the future work deployment of Shenzhen Cell Valley and its subsidiaries, clarify work objectives, gather development consensus, and help the company and employees develop together, on the afternoon of October 30, 2023, the group held a general meeting of all employees, and the founder Chairman Shi Yuanyuan made a keynote report on the topic of "ushering in the growth turning point and seizing the opportunities of The Times". Wang Jianxun, Deputy general manager and chief scientist of the Group, Xiang Hua, Tang Xiaomeng, and all employees of Shenzhen headquarters and wholly-owned subsidiaries Junhou Biology and Jingshen Cell Valley participated in the meeting through online and offline means.

Chairman Shi Yuanyuan made a speech on the topic of industry situation analysis, honor performance highlights, internal construction, challenge opportunities and goals.
Chairman Shi Yuanyuan first analyzed the development of the domestic and international CGT industry, emphasizing that the overall development of the industry is rapid, but the exploration of enterprises have ups and downs, investment and financing into the capital winter, the CGT industry is facing the coexistence of challenges and opportunities. Enterprises are more competitive in scientific and technological strength, management ability and strategic focus. As a technology-driven enterprise, we should have the courage to face challenges, seize the opportunities of The Times, strengthen differentiated development, find the right profit model, and create contrarian growth in the winter of capital.
Chairman Shi Yuanyuan said that in the year since Shenzhen Cell Valley started construction and officially put into operation and production, in accordance with the overall strategic planning and layout of the board of directors, production, research and development, quality control, market and other works were carried out in an orderly manner, and more than ten awards were approved as well as municipal and district-level projects, which has achieved steady market development and rapid sales growth. And with Lu Daopei International Medical Group, Fosun Kate and other industry leaders to establish a comprehensive strategic partnership, the strength of the enterprise is increasing. At present, Shenzhen Cell Valley has ushered in an inflection point of growth. We will closely focus on the company's strategic goals, constantly improve the quality of products and services, improve core competitiveness, and form an enterprise advantage. And carry out personnel training services, cooperate with multiple parties to build the industry ecology, and steadily expand the national and overseas markets. At the same time, improve the enterprise management system, strengthen the construction of corporate culture, and lay a solid foundation for the sustainable and sound development of the company.
This keynote report further clarified the vision and positioning of the company, and all staff of Shenzhen Cell Valley have always adhered to the original heart of "cells benefit sentient beings, genes create the future" and pushed forward. All departments have unified ideas, firm confidence in development, clear work ideas, clear targets, effectively enhance the sense of responsibility and sense of urgency to promote the development of the company, and go all out to break through the key tasks and business objectives in 2023.